share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4:持股變動聲明-董事 McMullen Michael R.
美股SEC公告 ·  10/03 05:44

牛牛AI助理已提取核心訊息

Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. Specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. Specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed in the announcement.
邁克爾·R·麥克馬倫與施貴寶(BMY)有關聯,並於2024年9月30日參與了一筆涉及該公司股票的交易。關於交易性質的具體細節,包括交易股數、交易價格和最終的參股金融情況,在公告中沒有披露。
邁克爾·R·麥克馬倫與施貴寶(BMY)有關聯,並於2024年9月30日參與了一筆涉及該公司股票的交易。關於交易性質的具體細節,包括交易股數、交易價格和最終的參股金融情況,在公告中沒有披露。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。